Skip to content

4/AAccepted Sep 30, 9:19 PM ET

Rankin Aubrey 4/A

RVNCRevance Therapeutics, Inc.

Accepted (ET)

9:19 PM

Sep 30, 2020

Filed

Sep 30, 2020

Documents

1

Size

7.8 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.